Mesenchymal Cell News 10.07 February 20, 2018 | |
| |
TOP STORYResearchers identified lead cardioactive human MSC exosomal microRNAs to provide a mechanistic basis for optimizing future stem cell-based cardiotherapies. [Circ Res] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROA Modular Strategy to Engineer Complex Tissues and Organs A successful tracheal replacement must have radial rigidity to prevent airway collapse during respiration, contain an immunoprotective respiratory epithelium, and integrate with the host vasculature to support epithelium viability. Herein, biopolymer microspheres were used to deliver chondrogenic growth factors to human MSCs seeded in a custom mold that self-assemble into cartilage rings, which can be fused into tubes. [Adv Sci] Full Article The authors found that alteration of the brains’ microenvironment by acute hypothermia treatment modulates MSC function resulting in a pro-inflammatory environment combined with alteration of the homeostatic growth factor milieu in the neonatal hypoxic-ischemic brain. [Brain Behav Immun] Full Article Hematogenous Dissemination of Mesenchymal Stem Cells from Endometriosis Investigators determined if cells derived from endometriosis could enter vascular circulation and lead to hematogenous dissemination. [Stem Cells] Abstract By using an immortalized human MSC line model, investigators showed that both N- and O-glycan processing in the Golgi functionally modulates early steps of osteogenic differentiation. [J Cell Sci] Full Article Murine bone marrow-derived MSCs (mMSCs) were isolated and grown in conditioned medium derived from gastric cancer cell line MFC. The tumor-promoting phenotype and function of mMSCs were detected by immunofluorescence staining, quantitative reverse transcription-polymerase chain reaction, cell colony formation assay, transwell migration, and invasion assays. [Cancer Med] Full Article IN VIVOUsing in vitro co-culture of rat cortical primary neurons and MSCs in hypoxic-ischemic (HI) conditions, scientists demonstrated that MSCs help increase BDNF and autophagy markers in the cultures and decrease cells death. They demonstrated a similar mechanism using an in vivo rat model of HI in combination with MSCs transplantation. [Stem Cells] Abstract Scientists explored the potential therapeutic benefits of the transplantation of CXCR2-overexpressing MSCs (MSCsCXCR2) for mucositis treatment. MSCsCXCR2 exhibited enhanced targeting ability to the inflamed mucosa in radiation/chemical-induced oral mucositis mouse models. [Cell Death Dis] Full Article Researchers coated mouse adipose tissue-derived MSC with antibodies directed against kidney injury molecule-1, which is upregulated in injured kidneys, and tested the hypothesis that this would enhance their therapeutic effects in ischemic kidney injury. [Stem Cells Transl Med] Full Article Scientists investigated the therapeutic effect of bone MSCs that were genetically modified to overexpress transforming growth factor-beta 3 (TGF-β3), an inhibitor of myofibroblast proliferation and collagen type I deposition, on full-thickness cutaneous wound healing in a rabbit model. [Exp Cell Res] Abstract | |
| |
REVIEWSUnderstanding the biological factors responsible for subdued responses of MSCs in vivo would allow uninhibited use of this therapy for countless conditions. Scientists summarize the variations in the preclinical and clinical studies utilizing MSCs, discuss the factors which might be responsible for variability in outcome and propose the advancements likely to occur in future for using this as a “boutique/personalised therapy” for patient care. [J Transl Med] Full Article Investigators reviewed the role of bone marrrow MSCs in regulating axon regeneration and glial scar formation after spinal cord injury. [Neurochem Int] Abstract Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSBone Therapeutics Completes Patient Recruitment for Phase IIa Spinal Fusion Study with ALLOB® Bone Therapeutics announced that it has completed the recruitment of its Phase IIa lumbar spinal fusion study with its allogeneic bone-cell therapy product, ALLOB®. [Bone Therapeutics S.A.] Press Release Smithfield Bioscience and University of Virginia Announce Regenerative Medicine Research Partnership Smithfield Foods, Inc. and the University of Virginia School of Engineering & Applied Science announced a research partnership to explore and advance regenerative medicine technologies leveraging porcine bioproducts. [CSRwire LLC.] Press Release | |
| |
POLICY NEWSIndonesian Scientists Hamstrung by Year-Long Funding Delay Indonesian scientists expecting to receive hundreds of thousands of dollars for research are stuck in limbo because the country’s first dedicated science-funding agency is struggling to raise enough money. [Nature News] Editorial Italian Election Leaves Science Out in the Cold As campaigning ahead of Italy’s national election enters its final weeks, researchers in the country fear that budget cuts and declining interest in science will only continue — whatever the outcome of the vote. [Nature News] Editorial Biden Blasts Science Denialists, Calls to Dramatically Speed Up Fight against Cancer Fresh off a plane from the NATO meeting in Munich, where he’d conferred with world leaders on global defense, former U.S. Vice President Joe Biden issued a forceful call here last night to build on the “Cancer Moonshot” he started while in the White House and transform the way the world fights cancer. [ScienceInsider] Editorial
| |
EVENTSNEW Gordon Research Conferences: Notch Signaling in Development, Regeneration and Disease Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Research Associate – Obstetrics and Gynecology (University of Illinois) NEW Senior Stem Cell Scientist – Tissue Engineering (VitroLabs Inc) NEW Full Professor Position – Cell and Developmental Biology (Max F. Perutz Laboratories) Lectureship – Stem Cell Biology (University of Edinburgh) Scientist – Stem Cell and Regenerative Biology, (Moderna Therapeutics) Principal Investigator – Cardiac Cell Repair (Boston Children’s Hospital) PhD Studentship – Regenerative Sciences (Hannover Biomedical Research School) Assistant or Associate Professor – Orthopedics & Sports Medicine (University of Washington) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|